Showing results (271-280 of 887) with videos related to
Sort By:
Pageof 89
Journal of the American Society of Nephrology : JASN|October 25, 2001
Effects of retinoids on the TGF-beta system and extracellular matrix in experimental glomerulonephritisChristian Morath, Claudius Dechow, Ingo Lehrke, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 31, 2009
Arterial calcification in patients with chronic kidney diseaseNadezda Koleganova, Grzegorz Piecha, Eberhard Ritz, et al.European Heart Journal|May 5, 2010
Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiographyStefan Pilz, Andreas Tomaschitz, Christiane Drechsler, et al.Virchows Archiv : an International Journal of Pathology|April 10, 2003
Myocyte loss in early left ventricular hypertrophy of experimental renovascular hypertensionMoriz Buzello, Christoph Boehm, Stephan Orth, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 31, 2007
Target level for hemoglobin correction in patients with diabetes and CKD: primary results of the Anemia Correction in Diabetes (ACORD) StudyEberhard Ritz, Maurice Laville, Rudy W Bilous, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|February 4, 2009
Interstitial fibrosis and microvascular disease of the heart in uremia: amelioration by a calcimimeticNadezda Koleganova, Grzegorz Piecha, Eberhard Ritz, et al.Kidney & Blood Pressure Research|August 1, 2015
Administration of Cyclosporine A in Pregnant Rats - the Effect on Blood Pressure and on the Glomerular Number in Their OffspringNatalia Slabiak-Blaz, Marcin Adamczak, Nadezda Gut, et al.PPAR Research|March 27, 2012
Rosiglitazone affects nitric oxide synthases and improves renal outcome in a rat model of severe ischemia/reperfusion injuryBoris Betz, Reinhard Schneider, Tobias Kress, et al.Therapeutics and Clinical Risk Management|February 2, 2017
Advances in the management of cardiovascular risk for patients with type 2 diabetes: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 DiabetesGuntram Schernthaner, Sarah Jarvis, Chaim Lotan, et al.Journal of the American Society of Nephrology : JASN|October 29, 2014
Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKDGerald Schulman, Tomas Berl, Gerald J Beck, et al.Pageof 89